共 50 条
- [22] Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs FRONTIERS IN ONCOLOGY, 2023, 13
- [24] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458
- [27] Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer FRONTIERS IN ONCOLOGY, 2021, 11